CeraVx

Description

CeraVx develops ceramic CeraMaps microneedle patches for intradermal delivery of vaccines and medicines, using biocompatible, inert microneedles that penetrate the skin’s outer layer where immune cells reside.

CeraVx is located in the Netherlands ecosystem.

Related

• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
• CimCureCimCure develops cancer vaccines using its proprietary iBoost conjugate technology to induce immune responses that target and destroy…
• CytuvaxCytuvax develops cancer immunotherapy and vaccines for viral and bacterial pathogens, using depot-attached cytokines as immune-stimulating…
• Bavarian NordicBavarian Nordic researches, develops, and manufactures life-saving vaccines, maintains product and pipeline materials, and operates process…
• TTolerogenixxTolerogenixx develops personalized therapies using proprietary modified immune cell technology to target immune modulation, including…
• SynthonSynthon develops, manufactures, and commercializes complex generic medicines, combining research and development, manufacturing, and…
• LEO PharmaLEO Pharma develops and delivers innovative treatments for medical dermatology, producing medicines and supplying healthcare providers and…
• OncolinesOncolines provides precision medicine services in oncology and cancer immunotherapy, offering cell‑based assays, profiling platforms,…
• CutanosCutanos develops LC-TDS, a ligand-based delivery platform that uses langerin-specific glycomimetic ligands on lipid nanoparticles to…